Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors
- PMID: 22698992
- PMCID: PMC3665606
- DOI: 10.1016/j.bbi.2012.05.017
Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors
Abstract
Many survivors of breast cancer show significant cognitive impairments, including memory deficits. Inflammation induced by chemotherapy may contribute to hippocampal changes that underlie these deficits. In this cross-sectional study, we measured bilateral hippocampal volumes from high-resolution magnetic resonance images in 42 chemotherapy-treated breast cancer survivors and 35 healthy female controls. Patients with breast cancer were, on average, 4.8 ± 3.4 years off-therapy. In a subset of these participants (20 breast cancer, 23 controls), we quantified serum cytokine levels. Left hippocampal volumes and memory performance were significantly reduced and interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNFα) concentrations were significantly elevated in the breast cancer group compared to controls. In the breast cancer group, lower left hippocampal volume was associated with higher levels of TNFα and lower levels of IL-6 with a significant interaction between these two cytokines suggesting a potential modulatory effect of IL-6 on TNFα. Verbal memory performance was associated with cytokine levels and left hippocampal volume in both groups. These findings provide evidence of altered hippocampal volume and verbal memory difficulties following breast cancer chemotherapy that may be mediated by TNFα and IL-6.
Copyright © 2012. Published by Elsevier Inc.
Figures


Similar articles
-
Does tumor necrosis factor-alpha (TNF-α) play a role in post-chemotherapy cerebral dysfunction?Brain Behav Immun. 2013 Mar;30 Suppl(Suppl):S99-108. doi: 10.1016/j.bbi.2012.07.015. Epub 2012 Aug 3. Brain Behav Immun. 2013. PMID: 22884417 Free PMC article.
-
Neurotoxic Effects of Anthracycline- vs Nonanthracycline-Based Chemotherapy on Cognition in Breast Cancer Survivors.JAMA Oncol. 2016 Feb;2(2):185-92. doi: 10.1001/jamaoncol.2015.4333. JAMA Oncol. 2016. PMID: 26633037 Free PMC article.
-
Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma.J Clin Oncol. 2002 Jan 15;20(2):485-93. doi: 10.1200/JCO.2002.20.2.485. J Clin Oncol. 2002. PMID: 11786578
-
Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy.J Clin Oncol. 2012 Oct 10;30(29):3578-87. doi: 10.1200/JCO.2011.39.5640. Epub 2012 Aug 27. J Clin Oncol. 2012. PMID: 22927526 Free PMC article. Review.
-
Clearing the fog: a review of the effects of dietary omega-3 fatty acids and added sugars on chemotherapy-induced cognitive deficits.Breast Cancer Res Treat. 2017 Feb;161(3):391-398. doi: 10.1007/s10549-016-4073-8. Epub 2016 Dec 8. Breast Cancer Res Treat. 2017. PMID: 27933449 Free PMC article. Review.
Cited by
-
A feasibility study exploring the role of pre-operative assessment when examining the mechanism of 'chemo-brain' in breast cancer patients.Springerplus. 2016 Mar 31;5:390. doi: 10.1186/s40064-016-2030-y. eCollection 2016. Springerplus. 2016. PMID: 27047716 Free PMC article.
-
Pathogenesis, Assessments, and Management of Chemotherapy-Related Cognitive Impairment (CRCI): An Updated Literature Review.J Oncol. 2020 Jun 24;2020:3942439. doi: 10.1155/2020/3942439. eCollection 2020. J Oncol. 2020. PMID: 32684930 Free PMC article. Review.
-
Cancer-related inflammation and depressive symptoms: Systematic review and meta-analysis.Cancer. 2022 Jul 1;128(13):2504-2519. doi: 10.1002/cncr.34193. Epub 2022 Apr 13. Cancer. 2022. PMID: 35417925 Free PMC article.
-
Potential Molecular Biomarkers of Central Nervous System Damage in Breast Cancer Survivors.J Clin Med. 2022 Feb 24;11(5):1215. doi: 10.3390/jcm11051215. J Clin Med. 2022. PMID: 35268306 Free PMC article.
-
Cognitive effects of cancer and its treatments at the intersection of aging: what do we know; what do we need to know?Semin Oncol. 2013 Dec;40(6):709-25. doi: 10.1053/j.seminoncol.2013.09.006. Semin Oncol. 2013. PMID: 24331192 Free PMC article. Review.
References
-
- Abercrombie HC, Giese-Davis J, Sephton S, Epel ES, Turner-Cobb JM, Spiegel D. Flattened cortisol rhythms in metastatic breast cancer patients. Psychoneuroendocrinology. 2004;29:1082–1092. - PubMed
-
- Aghakhani A, Chan EK. Test Reviews: Bracken, B.A., Howell, K. (2004). Clinical Assessment of Depression. Odessa, FL: Psychological Assessment Resources. J. Psycho. Assess. 2007;25:416–422.
-
- Ahles TA, Saykin AJ, Furstenberg CT, Cole B, Mott LA, Skalla K, Whedon MB, Bivens S, Mitchell T, Greenberg ER, Silberfarb PM. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J. Clin. Oncol. 2002;20:485–493. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical